Study Subjects and Ordinary Patients View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-07

AUTHORS

R. Dowd, R. R. Recker, R. P. Heaney

ABSTRACT

: Clinical trials of treatment agents impose strict and often necessary inclusion and exclusion criteria, while patients presenting to physicians for treatment frequently exhibit complicating features that would have excluded them from entry into study. To quantify the degree of discordance between ordinary patients and study subjects, a retrospective chart review was carried out of all new patients with osteoporosis seen in an academic medical center within a consecutive 40-month period, meeting clinical treatment criteria. Each patient chart was reviewed for the inclusion and exclusion criteria of four large, multicenter study protocols. There were 120 consecutive female patients seeking health care, with bone density T-scores below −2.0 and/or with one or more low-trauma fractures. The four trials would have accepted 4, 5, 25 and 8 of our 120 patients. The trial with the most liberal inclusion criteria would have taken only 21% of the total. Principal reasons for ineligibility were comorbidity, prior treatment with bone-active agents, and current therapy with glucocorticoids, anticoagulants and anticonvulsants. Some of these exclusions inevitably reflect the patient mix of a referral center; nevertheless, comorbidity and its therapy are common in the age range in which osteoporosis is prevalent and would, therefore, be expected to be present in patients in general medical practice as well. Thus a large fraction, perhaps the majority, of patients with diagnoses of osteoporosis who are candidates for treatment by their physicians, are not eligible for entry into typical treatment trials. The results of such trials may, therefore, have uncertain applicability to types of patients excluded, both for safety and for efficacy. More... »

PAGES

533-536

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s001980070097

DOI

http://dx.doi.org/10.1007/s001980070097

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1029162607

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10982170


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Comorbidity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Controlled Clinical Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Osteoporosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Selection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Selection Bias", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Creighton University, Osteoporosis Research Center, Omaha, Nebraska, USA, US", 
          "id": "http://www.grid.ac/institutes/grid.254748.8", 
          "name": [
            "Creighton University, Osteoporosis Research Center, Omaha, Nebraska, USA, US"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dowd", 
        "givenName": "R.", 
        "id": "sg:person.0744261242.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744261242.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Creighton University, Osteoporosis Research Center, Omaha, Nebraska, USA, US", 
          "id": "http://www.grid.ac/institutes/grid.254748.8", 
          "name": [
            "Creighton University, Osteoporosis Research Center, Omaha, Nebraska, USA, US"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Recker", 
        "givenName": "R. R.", 
        "id": "sg:person.016325222544.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016325222544.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Creighton University, Osteoporosis Research Center, Omaha, Nebraska, USA, US", 
          "id": "http://www.grid.ac/institutes/grid.254748.8", 
          "name": [
            "Creighton University, Osteoporosis Research Center, Omaha, Nebraska, USA, US"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Heaney", 
        "givenName": "R. P.", 
        "id": "sg:person.0645437522.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645437522.96"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2000-07", 
    "datePublishedReg": "2000-07-01", 
    "description": "Abstract: Clinical trials of treatment agents impose strict and often necessary inclusion and exclusion criteria, while patients presenting to physicians for treatment frequently exhibit complicating features that would have excluded them from entry into study. To quantify the degree of discordance between ordinary patients and study subjects, a retrospective chart review was carried out of all new patients with osteoporosis seen in an academic medical center within a consecutive 40-month period, meeting clinical treatment criteria. Each patient chart was reviewed for the inclusion and exclusion criteria of four large, multicenter study protocols. There were 120 consecutive female patients seeking health care, with bone density T-scores below \u22122.0 and/or with one or more low-trauma fractures. The four trials would have accepted 4, 5, 25 and 8 of our 120 patients. The trial with the most liberal inclusion criteria would have taken only 21% of the total. Principal reasons for ineligibility were comorbidity, prior treatment with bone-active agents, and current therapy with glucocorticoids, anticoagulants and anticonvulsants. Some of these exclusions inevitably reflect the patient mix of a referral center; nevertheless, comorbidity and its therapy are common in the age range in which osteoporosis is prevalent and would, therefore, be expected to be present in patients in general medical practice as well. Thus a large fraction, perhaps the majority, of patients with diagnoses of osteoporosis who are candidates for treatment by their physicians, are not eligible for entry into typical treatment trials. The results of such trials may, therefore, have uncertain applicability to types of patients excluded, both for safety and for efficacy.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s001980070097", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100834", 
        "issn": [
          "0937-941X", 
          "1433-2965"
        ], 
        "name": "Osteoporosis International", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "keywords": [
      "exclusion criteria", 
      "bone density T-score", 
      "ordinary patients", 
      "multicenter study protocol", 
      "liberal inclusion criteria", 
      "retrospective chart review", 
      "low-trauma fractures", 
      "consecutive female patients", 
      "types of patients", 
      "general medical practice", 
      "diagnosis of osteoporosis", 
      "academic medical center", 
      "bone active agents", 
      "chart review", 
      "referral center", 
      "patient charts", 
      "female patients", 
      "treatment trials", 
      "current therapies", 
      "study protocol", 
      "clinical trials", 
      "treatment criteria", 
      "inclusion criteria", 
      "new patients", 
      "Medical Center", 
      "patients", 
      "study subjects", 
      "T-score", 
      "prior treatment", 
      "such trials", 
      "osteoporosis", 
      "patient mix", 
      "trials", 
      "degree of discordance", 
      "age range", 
      "health care", 
      "comorbidities", 
      "therapy", 
      "treatment agents", 
      "medical practice", 
      "treatment", 
      "physicians", 
      "subjects", 
      "anticoagulants", 
      "anticonvulsants", 
      "complicating features", 
      "glucocorticoids", 
      "criteria", 
      "agents", 
      "ineligibility", 
      "diagnosis", 
      "care", 
      "efficacy", 
      "uncertain applicability", 
      "total", 
      "center", 
      "discordance", 
      "principal reason", 
      "entry", 
      "fractures", 
      "safety", 
      "review", 
      "majority", 
      "charts", 
      "period", 
      "inclusion", 
      "study", 
      "protocol", 
      "exclusion", 
      "practice", 
      "candidates", 
      "reasons", 
      "fraction", 
      "types", 
      "degree", 
      "features", 
      "results", 
      "large fraction", 
      "necessary inclusion", 
      "range", 
      "mix", 
      "applicability"
    ], 
    "name": "Study Subjects and Ordinary Patients", 
    "pagination": "533-536", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1029162607"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s001980070097"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10982170"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s001980070097", 
      "https://app.dimensions.ai/details/publication/pub.1029162607"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T16:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_326.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s001980070097"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s001980070097'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s001980070097'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s001980070097'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s001980070097'


 

This table displays all metadata directly associated to this object as RDF triples.

201 TRIPLES      20 PREDICATES      119 URIs      111 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s001980070097 schema:about N1d81e634b84c4f929cb625031987a274
2 N2858dd9f1cfe49f9ac3b9bb50056d39c
3 N5d527c28bcd446359ff24f2682fdde9c
4 N5e590658b62b43b88274045a048c10e9
5 N84a58c3b35bd45bca2bdc6a9fc1920af
6 Na6fc31e045434b4293ac1edc8c0c6eeb
7 Naaf63563cb974cc58cd0c87df676c842
8 Nbf90a94de55548569108a0eb2cebadc1
9 Nc207fa9ca3084aae87961c9a9bbe6fda
10 Ne8905b0964c44106a578b8d8a2ca861c
11 Nfe07809326c541a6aa23769bdd8f9147
12 anzsrc-for:11
13 anzsrc-for:1103
14 schema:author N26c5dd46d2c84f57b968d3322d79cd2b
15 schema:datePublished 2000-07
16 schema:datePublishedReg 2000-07-01
17 schema:description Abstract: Clinical trials of treatment agents impose strict and often necessary inclusion and exclusion criteria, while patients presenting to physicians for treatment frequently exhibit complicating features that would have excluded them from entry into study. To quantify the degree of discordance between ordinary patients and study subjects, a retrospective chart review was carried out of all new patients with osteoporosis seen in an academic medical center within a consecutive 40-month period, meeting clinical treatment criteria. Each patient chart was reviewed for the inclusion and exclusion criteria of four large, multicenter study protocols. There were 120 consecutive female patients seeking health care, with bone density T-scores below −2.0 and/or with one or more low-trauma fractures. The four trials would have accepted 4, 5, 25 and 8 of our 120 patients. The trial with the most liberal inclusion criteria would have taken only 21% of the total. Principal reasons for ineligibility were comorbidity, prior treatment with bone-active agents, and current therapy with glucocorticoids, anticoagulants and anticonvulsants. Some of these exclusions inevitably reflect the patient mix of a referral center; nevertheless, comorbidity and its therapy are common in the age range in which osteoporosis is prevalent and would, therefore, be expected to be present in patients in general medical practice as well. Thus a large fraction, perhaps the majority, of patients with diagnoses of osteoporosis who are candidates for treatment by their physicians, are not eligible for entry into typical treatment trials. The results of such trials may, therefore, have uncertain applicability to types of patients excluded, both for safety and for efficacy.
18 schema:genre article
19 schema:isAccessibleForFree false
20 schema:isPartOf N32e451212f6a42f5810b2fe43db733a5
21 Nef76b89dabc34728bbd3cfd5f8983873
22 sg:journal.1100834
23 schema:keywords Medical Center
24 T-score
25 academic medical center
26 age range
27 agents
28 anticoagulants
29 anticonvulsants
30 applicability
31 bone active agents
32 bone density T-score
33 candidates
34 care
35 center
36 chart review
37 charts
38 clinical trials
39 comorbidities
40 complicating features
41 consecutive female patients
42 criteria
43 current therapies
44 degree
45 degree of discordance
46 diagnosis
47 diagnosis of osteoporosis
48 discordance
49 efficacy
50 entry
51 exclusion
52 exclusion criteria
53 features
54 female patients
55 fraction
56 fractures
57 general medical practice
58 glucocorticoids
59 health care
60 inclusion
61 inclusion criteria
62 ineligibility
63 large fraction
64 liberal inclusion criteria
65 low-trauma fractures
66 majority
67 medical practice
68 mix
69 multicenter study protocol
70 necessary inclusion
71 new patients
72 ordinary patients
73 osteoporosis
74 patient charts
75 patient mix
76 patients
77 period
78 physicians
79 practice
80 principal reason
81 prior treatment
82 protocol
83 range
84 reasons
85 referral center
86 results
87 retrospective chart review
88 review
89 safety
90 study
91 study protocol
92 study subjects
93 subjects
94 such trials
95 therapy
96 total
97 treatment
98 treatment agents
99 treatment criteria
100 treatment trials
101 trials
102 types
103 types of patients
104 uncertain applicability
105 schema:name Study Subjects and Ordinary Patients
106 schema:pagination 533-536
107 schema:productId N07b9e1761fca4cd9aded0b53318d4b08
108 N787d7af848e34e5dba53c94bd825eeb6
109 N8a0aad487ac643649e81bae35f422b96
110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029162607
111 https://doi.org/10.1007/s001980070097
112 schema:sdDatePublished 2022-08-04T16:54
113 schema:sdLicense https://scigraph.springernature.com/explorer/license/
114 schema:sdPublisher N8c019e67d0f74cfb848d656ed0e91c0c
115 schema:url https://doi.org/10.1007/s001980070097
116 sgo:license sg:explorer/license/
117 sgo:sdDataset articles
118 rdf:type schema:ScholarlyArticle
119 N07b9e1761fca4cd9aded0b53318d4b08 schema:name doi
120 schema:value 10.1007/s001980070097
121 rdf:type schema:PropertyValue
122 N1d81e634b84c4f929cb625031987a274 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Humans
124 rdf:type schema:DefinedTerm
125 N26c5dd46d2c84f57b968d3322d79cd2b rdf:first sg:person.0744261242.97
126 rdf:rest N6d2e630a8ffe463d9b5c25295688fe10
127 N2858dd9f1cfe49f9ac3b9bb50056d39c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Aged
129 rdf:type schema:DefinedTerm
130 N32e451212f6a42f5810b2fe43db733a5 schema:volumeNumber 11
131 rdf:type schema:PublicationVolume
132 N448fba67f8114f60b2621cf2d9d5b137 rdf:first sg:person.0645437522.96
133 rdf:rest rdf:nil
134 N5d527c28bcd446359ff24f2682fdde9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Aged, 80 and over
136 rdf:type schema:DefinedTerm
137 N5e590658b62b43b88274045a048c10e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Controlled Clinical Trials as Topic
139 rdf:type schema:DefinedTerm
140 N6d2e630a8ffe463d9b5c25295688fe10 rdf:first sg:person.016325222544.69
141 rdf:rest N448fba67f8114f60b2621cf2d9d5b137
142 N787d7af848e34e5dba53c94bd825eeb6 schema:name pubmed_id
143 schema:value 10982170
144 rdf:type schema:PropertyValue
145 N84a58c3b35bd45bca2bdc6a9fc1920af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Comorbidity
147 rdf:type schema:DefinedTerm
148 N8a0aad487ac643649e81bae35f422b96 schema:name dimensions_id
149 schema:value pub.1029162607
150 rdf:type schema:PropertyValue
151 N8c019e67d0f74cfb848d656ed0e91c0c schema:name Springer Nature - SN SciGraph project
152 rdf:type schema:Organization
153 Na6fc31e045434b4293ac1edc8c0c6eeb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Middle Aged
155 rdf:type schema:DefinedTerm
156 Naaf63563cb974cc58cd0c87df676c842 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Female
158 rdf:type schema:DefinedTerm
159 Nbf90a94de55548569108a0eb2cebadc1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Retrospective Studies
161 rdf:type schema:DefinedTerm
162 Nc207fa9ca3084aae87961c9a9bbe6fda schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Patient Selection
164 rdf:type schema:DefinedTerm
165 Ne8905b0964c44106a578b8d8a2ca861c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Selection Bias
167 rdf:type schema:DefinedTerm
168 Nef76b89dabc34728bbd3cfd5f8983873 schema:issueNumber 6
169 rdf:type schema:PublicationIssue
170 Nfe07809326c541a6aa23769bdd8f9147 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Osteoporosis
172 rdf:type schema:DefinedTerm
173 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
174 schema:name Medical and Health Sciences
175 rdf:type schema:DefinedTerm
176 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
177 schema:name Clinical Sciences
178 rdf:type schema:DefinedTerm
179 sg:journal.1100834 schema:issn 0937-941X
180 1433-2965
181 schema:name Osteoporosis International
182 schema:publisher Springer Nature
183 rdf:type schema:Periodical
184 sg:person.016325222544.69 schema:affiliation grid-institutes:grid.254748.8
185 schema:familyName Recker
186 schema:givenName R. R.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016325222544.69
188 rdf:type schema:Person
189 sg:person.0645437522.96 schema:affiliation grid-institutes:grid.254748.8
190 schema:familyName Heaney
191 schema:givenName R. P.
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645437522.96
193 rdf:type schema:Person
194 sg:person.0744261242.97 schema:affiliation grid-institutes:grid.254748.8
195 schema:familyName Dowd
196 schema:givenName R.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744261242.97
198 rdf:type schema:Person
199 grid-institutes:grid.254748.8 schema:alternateName Creighton University, Osteoporosis Research Center, Omaha, Nebraska, USA, US
200 schema:name Creighton University, Osteoporosis Research Center, Omaha, Nebraska, USA, US
201 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...